What Researchers Did
Researchers described the case of a 55-year-old man with chronic myeloid leukaemia who developed pneumatosis intestinalis during nilotinib chemotherapy.
What They Found
A 55-year-old man with chronic myeloid leukaemia developed pneumatosis intestinalis approximately 5 months after starting nilotinib. This condition resolved with five courses of hyperbaric oxygen therapy and other medications, while nilotinib was continued, leading to major and complete molecular responses for his leukaemia at 6 and 18 months, respectively.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, the findings of this study cannot be generalized to a broader patient population.